Business Process Transformation for Targeted Treatments in Life Sciences

Business Process Transformation for Targeted Treatments in Life Sciences
Life sciences businesses must drive new products to increase revenue and growth, promote innovation, and meet new regulatory challenges in a global business environment. GSK Biologicals, a division of GlaxoSmithKline plc, has developed a compelling business vision using SAP software across the company to meet these challenges. Learn what benefits GSK Biologicals has gained from a "why not SAP" approach.

Speaker(s):
Daniel Lebeau, Project Manager, GlaxoSmithKline Biologicals
Jim Sabogal, Director, SAP

Date of Issue:
21 mai 2008

Language:
Inglês

Event:
SAPPHIRE 2008 Berlin Online - Berlin, Germany (May, 2008)

Track:
Consumer and Life Sciences Industries

Solutions:
All Solutions / Services

Industries:
All Industries

Access the content: